Which statement is correct about educating clients on antiparkinson medications?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Which statement is correct about educating clients on antiparkinson medications?

Explanation:
Not abruptly stopping prescribed antiparkinson meds is essential because these drugs rely on steady dopaminergic stimulation to control symptoms. Sudden discontinuation can trigger a withdrawal-like reaction with a dangerous worsening of Parkinsonian symptoms, fever, autonomic instability, and confusion, and in some cases a life-threatening syndrome similar to neuroleptic malignant syndrome. Any change in therapy should be guided by a clinician, often involving a gradual taper or dose adjustment to maintain stable symptom control. If side effects occur, discuss them with the provider rather than stopping the medication on your own. Skipping doses or taking medication only when symptoms are severe disrupts the consistent dopaminergic support and can lead to more pronounced fluctuations and dyskinesias.

Not abruptly stopping prescribed antiparkinson meds is essential because these drugs rely on steady dopaminergic stimulation to control symptoms. Sudden discontinuation can trigger a withdrawal-like reaction with a dangerous worsening of Parkinsonian symptoms, fever, autonomic instability, and confusion, and in some cases a life-threatening syndrome similar to neuroleptic malignant syndrome. Any change in therapy should be guided by a clinician, often involving a gradual taper or dose adjustment to maintain stable symptom control. If side effects occur, discuss them with the provider rather than stopping the medication on your own. Skipping doses or taking medication only when symptoms are severe disrupts the consistent dopaminergic support and can lead to more pronounced fluctuations and dyskinesias.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy